Parental IBD and Long-term Health Outcomes in the Offspring.
暂无分享,去创建一个
[1] M. Fraenkel,et al. Maternal Hypothyroidism during Pregnancy and the Risk of Pediatric Endocrine Morbidity in the Offspring , 2018, American Journal of Perinatology.
[2] M. Lukáš,et al. Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation. , 2018, Inflammatory bowel diseases.
[3] A. Barkun,et al. Continuous Anti‐TNF&agr; Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION) , 2018, The American Journal of Gastroenterology.
[4] T. Yorifuji,et al. Genetic basis of early‐onset, maturity‐onset diabetes of the young‐like diabetes in Japan and features of patients without mutations in the major MODY genes: Dominance of maternal inheritance , 2018, Pediatric diabetes.
[5] G. Veerappan. Continuing Medical Education Questions: March 2018: Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study , 2018, The American Journal of Gastroenterology.
[6] J. Gisbert,et al. Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study , 2018, The American Journal of Gastroenterology.
[7] B. Nørgård,et al. Birth outcomes after preconception paternal exposure to methotrexate: A nationwide cohort study. , 2017, Reproductive toxicology.
[8] B. Nørgård,et al. Paternal use of azathioprine/6-mercaptopurine or methotrexate within 3 months before conception and long-term health outcomes in the offspring-A nationwide cohort study. , 2017, Reproductive toxicology.
[9] Å. Lernmark,et al. Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity , 2017, European Thyroid Journal.
[10] B. Nørgård,et al. The Association Between Maternal Chronic Inflammatory Bowel Disease and Long-term Health Outcomes in Children—A Nationwide Cohort Study , 2017, Inflammatory bowel diseases.
[11] B. Nørgård,et al. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease , 2017, Inflammatory bowel diseases.
[12] B. Nørgård,et al. Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception , 2016, The American Journal of Gastroenterology.
[13] B. Nørgård,et al. Reassuring results on birth outcomes in children fathered by men treated with azathioprine/6-mercaptopurine within 3 months before conception: a nationwide cohort study , 2016, Gut.
[14] D. Landau,et al. Maternal Inflammatory Bowel Disease During Pregnancy is Not a Risk Factor for Long-term Morbidity of the Offspring. , 2016, Journal of Crohn's & colitis.
[15] H. Sørensen,et al. Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti-Tumor Necrosis Factor Agents During Pregnancy. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[16] D. Greenwald,et al. Review article: the safety of therapeutic drugs in male inflammatory bowel disease patients wishing to conceive , 2015, Alimentary pharmacology & therapeutics.
[17] Vibeke Andersen,et al. Familial Risk of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977–2011 , 2015, The American Journal of Gastroenterology.
[18] C. J. van der Woude,et al. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. , 2015, Journal of Crohn's & colitis.
[19] H. Sørensen,et al. Autism spectrum disorders in children of parents with inflammatory bowel disease – a nationwide cohort study in Denmark , 2014, Clinical and experimental gastroenterology.
[20] M. Lukáš,et al. Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children , 2014, Inflammatory bowel diseases.
[21] Diana Anderson,et al. Male-mediated developmental toxicity , 2013, Asian journal of andrology.
[22] S. Reif,et al. Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: a multicenter study in Israel. , 2013, Journal of Crohn's & colitis.
[23] H. Sørensen,et al. Parental Inflammatory Bowel Disease and Risk of Asthma in Offspring: A Nationwide Cohort Study in Denmark , 2013, Clinical and Translational Gastroenterology.
[24] C. Kneepkens,et al. Long‐term follow‐up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease , 2013, Alimentary pharmacology & therapeutics.
[25] A. Hubalewska-Dydejczyk,et al. How Far Are We from Understanding the Genetic Basis of Hashimoto's Thyroiditis? , 2013, International reviews of immunology.
[26] A. Engeland,et al. Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers , 2012, Scandinavian journal of rheumatology.
[27] I S Kohane,et al. Identification of autoimmune gene signatures in autism , 2011, Translational Psychiatry.
[28] T. Tomson,et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry , 2011, The Lancet Neurology.
[29] W. Reinisch,et al. Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. , 2011, Journal of Crohn's & colitis.
[30] F. Granath,et al. Congenital abnormalities and other birth outcomes in children born to women with ulcerative colitis in Denmark and Sweden , 2011, Inflammatory bowel diseases.
[31] J. Barrett,et al. New IBD genetics: common pathways with other diseases , 2011, Gut.
[32] L. Mackillop,et al. European evidenced-based consensus on reproduction in inflammatory bowel disease. , 2010, Journal of Crohn's & colitis.
[33] P. Sparén,et al. Parental Autoimmune Diseases Associated With Autism Spectrum Disorders in Offspring , 2010, Epidemiology.
[34] H. Sørensen,et al. Crohn's disease is a risk factor for preterm birth. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[35] K. Hemminki,et al. Familial Association of Inflammatory Bowel Diseases With Other Autoimmune and Related Diseases , 2010, The American Journal of Gastroenterology.
[36] C. Lees,et al. Genetics of inflammatory bowel disease: implications for disease pathogenesis and natural history , 2009, Expert review of gastroenterology & hepatology.
[37] P. Mortensen,et al. Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders , 2009, Pediatrics.
[38] D. Corley,et al. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. , 2007, Gastroenterology.
[39] B. Nørgård,et al. Disease Activity in Pregnant Women With Crohn's Disease and Birth Outcomes: A Regional Danish Cohort Study , 2007, The American Journal of Gastroenterology.
[40] L. Herrinton,et al. Clustering of Inflammatory Bowel Disease With Immune Mediated Diseases Among Members of a Northern California-Managed Care Organization , 2007, The American Journal of Gastroenterology.
[41] S. E. Mouridsen,et al. Autoimmune diseases in parents of children with infantile autism: a case—control study , 2007, Developmental medicine and child neurology.
[42] P. Tekkis,et al. A meta-analysis on the influence of inflammatory bowel disease on pregnancy , 2006, Gut.
[43] P. Ashwood,et al. The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.
[44] J. Lewis,et al. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. , 2005, Gastroenterology.
[45] C. Bernstein,et al. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. , 2005, Gastroenterology.
[46] A. Scialli,et al. The transport of chemicals in semen. , 2005, Birth defects research. Part B, Developmental and reproductive toxicology.
[47] B. Nørgård,et al. The risk of congenital abnormalities in children fathered by men treated with azathioprine or mercaptopurine before conception , 2004, Alimentary pharmacology & therapeutics.
[48] A. Ekbom. The Epidemiology of IBD: A Lot of Data but Little Knowledge. How Shall We Proceed? , 2004, Inflammatory bowel diseases.
[49] E. Lindberg,et al. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. , 2003, Gastroenterology.
[50] W. Webster,et al. Prescription drugs and pregnancy , 2003, Expert opinion on pharmacotherapy.
[51] G. Koren,et al. Effect of methotrexate on male fertility. , 2003, Canadian family physician Medecin de famille canadien.
[52] E. Boyko,et al. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study , 2002, American Journal of Gastroenterology.
[53] C. Mittermaier,et al. Azathioprine treatment and male fertility in inflammatory bowel disease. , 2001, Gastroenterology.
[54] W. Webster,et al. Is this drug safe in pregnancy? , 2001, Reproductive toxicology.
[55] H. Sørensen,et al. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study , 2000, American Journal of Gastroenterology.
[56] M. Orholm, V. Binder, T. I. A. Sørensen, L. P. Ras. Concordance of Inflammatory Bowel Disease among Danish Twins: Results of a Nationwide Study , 2000 .
[57] J. Trasler,et al. Teratogen update: paternal exposures-reproductive risks. , 1999, Teratology.
[58] H. Sørensen,et al. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries , 1998, American Journal of Gastroenterology.
[59] B. Korelitz,et al. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease , 1998, American Journal of Gastroenterology.
[60] S. Cnattingius,et al. Pregnancy outcomes in women with inflammatory bowel disease--a population-based cohort study. , 1997, American journal of obstetrics and gynecology.
[61] R. Pounder,et al. Genetics versus environment in inflammatory bowel disease: results of a British twin study , 1996, BMJ.
[62] D. Anderson,et al. Malformed foetuses and karyotype abnormalities in the offspring of cyclophosphamide and allyl alcohol-treated male rats. , 1990, Mutation research.
[63] Sumner J. Yaffe,et al. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 8th Edition , 1986 .
[64] A. Levi,et al. MALE INFERTILITY DUE TO SULPHASALAZINE , 1979, The Lancet.
[65] Davis Jg. Letter: Curious curd. , 1975 .
[66] C. Chambers,et al. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease. , 2017, Gastroenterology.
[67] Subrata Ghosh,et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.
[68] Yulian Zhao,et al. Effects of Pharmaceutical Medications on Male Fertility , 2012, Journal of reproduction & infertility.
[69] Kevin G Becker,et al. Autism, asthma, inflammation, and the hygiene hypothesis. , 2007, Medical hypotheses.
[70] James L. Schardein,et al. Chemically Induced Birth Defects , 1985 .